Prognostic value, immune signature and molecular mechanisms of the sumo family in pancreatic adenocarcinoma

HIGHLIGHTS

• who: SUMO family et al. from the Shenyang Pharmaceutical University, China have published the article: Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma, in the Journal: (JOURNAL)
• what: The authors performed a variety of bioinformatics analyses of publicly available data to comprehensively investigate the possible mechanisms by which SUMO family members might be involved in PAAD occurrence and development. The authors propose a possible oncogenic mechanism involving the high expression of SUMO family members, which increases the expression levels of M6A methylation regulators and in turn increases the oncogenic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.